Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 05, 2017 Filed Jul 6, 2017 21:02 UTC |
MORGAN HARVEYDirector
|
GiftCommon Stock | 4,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000068 · certent-form4.xml · nonDerivative · entry 1 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,932 F1 · shares: 4,367 shares were gifted by the reporting person to a trust for the benefit of his spouse for no consideration. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 21:03 UTC |
Benson JamesDirector
|
Disposition to issuerCommon Stock | 2,000 | $19.95 | $39,900.00 |
DisclosureSEC source: 0000784199-17-000070 · certent-form4.xml · nonDerivative · entry 1 Benson James · CIK 0001308620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,086 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. Read SEC document |
| June 30, 2017 Filed Jul 11, 2017 12:58 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 714 | $0.00 Strike: $16.28 | $0.00 |
DisclosureSEC source: 0000784199-17-000074 · certent-form5.xml · derivative · entry 9 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 714 shares Expires 2017-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2017 Filed Jul 11, 2017 12:58 UTC |
Holloway Jean FVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 714 | $0.00 Strike: $16.28 | $0.00 |
DisclosureSEC source: 0000784199-17-000074 · certent-form5.xml · derivative · entry 8 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714 Underlying: Common Stock · 714 shares Expires 2017-07-30 Read SEC document |
| June 30, 2017 Filed Jul 11, 2017 12:58 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 714 | $16.28 | $11,622.14 |
DisclosureSEC source: 0000784199-17-000074 · certent-form5.xml · nonDerivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| June 30, 2017 Filed Jul 11, 2017 12:56 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,305 | $0.00 Strike: $16.28 | $0.00 |
DisclosureSEC source: 0000784199-17-000072 · certent-form5.xml · derivative · entry 6 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,305 shares Expires 2017-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2017 Filed Jul 11, 2017 12:56 UTC |
Davis John ESenior VP, Global Sales
|
GrantStock Option (Right to Buy) · Derivative | 1,305 | $0.00 Strike: $16.28 | $0.00 |
DisclosureSEC source: 0000784199-17-000072 · certent-form5.xml · derivative · entry 5 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,305 Underlying: Common Stock · 1,305 shares Expires 2017-06-30 Read SEC document |
| June 30, 2017 Filed Jul 11, 2017 12:56 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 1,305 | $16.28 | $21,242.14 |
DisclosureSEC source: 0000784199-17-000072 · certent-form5.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 13:19 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 18,667 | $0.00 Strike: $5.12 | $0.00 |
DisclosureSEC source: 0000784199-17-000065 · certent-form4.xml · derivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,667 shares Expires 2018-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vested 33 1/3% per year beginning on the first anniversary of the grant date (February 23, 2012). Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 13:19 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 9,577 | $20.00 | $191,540.00 |
DisclosureSEC source: 0000784199-17-000065 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,705 F1 · kind: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 9, 2017. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 13:19 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 18,667 | $5.12 | $95,575.04 |
DisclosureSEC source: 0000784199-17-000065 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 24, 2017 13:21 UTC |
McCall Ronald DDirector
|
Disposition to issuerCommon Stock | 7,000 | $18.28 | $127,938.30 |
DisclosureSEC source: 0000784199-17-000063 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,511 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 12, 2016. F2 · price: Reflects weighted average price. Range of prices were between $18.20 to $18.40. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:45 UTC |
MORGAN HARVEYDirector
|
GrantCommon Stock | 5,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000059 · certent-form4.xml · nonDerivative · entry 1 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,299 F1 · shares: Represents shares of restricted stock that vest on the first anniversary of the grant date if the reporting person remains a member of the Company's board of directors, subject to earlier vesting upon certain events including death, disability and retirement from the board after serving out his full term because the director is not standing for re-election at the end of the term. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:43 UTC |
Salveson Jon WDirector
|
GrantCommon Stock | 5,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000057 · certent-form4.xml · nonDerivative · entry 1 Salveson Jon W · CIK 0001372026 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,349 F1 · shares: Represents shares of restricted stock that vest on the first anniversary of the grant date if the reporting person remains a member of the Company's board of directors, subject to earlier vesting upon certain events including death, disability and retirement from the board after serving out his full term because the director is not standing for re-election at the end of the term. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:39 UTC |
McCall Ronald DDirector
|
GrantCommon Stock | 5,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000055 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,511 F1 · shares: Represents shares of restricted stock that vest on the first anniversary of the grant date if the reporting person remains a member of the Company's board of directors, subject to earlier vesting upon certain events including death, disability and retirement from the board after serving out his full term because the director is not standing for re-election at the end of the term. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:35 UTC |
RONALD C ELKINSDirector
|
GrantCommon Stock | 5,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000053 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,849 F1 · shares: Represents shares of restricted stock that vest on the first anniversary of the grant date if the reporting person remains a member of the Company's board of directors, subject to earlier vesting upon certain events including death, disability and retirement from the board after serving out his full term because the director is not standing for re-election at the end of the term. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:33 UTC |
Bullock JamesDirector
|
GrantCommon Stock | 5,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000051 · certent-form4.xml · nonDerivative · entry 1 Bullock James · CIK 0001172340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,266 F1 · shares: Represents shares of restricted stock that vest on the first anniversary of the grant date if the reporting person remains a member of the Company's board of directors, subject to earlier vesting upon certain events including death, disability and retirement from the board after serving out his full term because the director is not standing for re-election at the end of the term. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:24 UTC |
BEVEVINO DANIEL JDirector
|
GrantCommon Stock | 5,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000048 · certent-form4.xml · nonDerivative · entry 1 BEVEVINO DANIEL J · CIK 0001186458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,349 F1 · shares: Represents shares of restricted stock that vest on the first anniversary of the grant date if the reporting person remains a member of the Company's board of directors, subject to earlier vesting upon certain events including death, disability and retirement from the board after serving out his full term because the director is not standing for re-election at the end of the term. Read SEC document |
| May 17, 2017 Filed May 18, 2017 20:23 UTC |
ACKERMAN THOMAS FDirector
|
GrantCommon Stock | 5,263 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000046 · certent-form4.xml · nonDerivative · entry 1 ACKERMAN THOMAS F · CIK 0001141720 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,349 F1 · shares: Represents shares of restricted stock that vest on the first anniversary of the grant date if the reporting person remains a member of the Company's board of directors, subject to earlier vesting upon certain events including death, disability and retirement from the board after serving out his full term because the director is not standing for re-election at the end of the term. Read SEC document |
| April 03, 2017 Filed Apr 10, 2017 20:57 UTC |
Benson JamesDirector
|
Disposition to issuerCommon Stock | 2,000 | $16.60 | $33,200.00 |
DisclosureSEC source: 0000784199-17-000042 · certent-form4.xml · nonDerivative · entry 1 Benson James · CIK 0001308620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,086 F1 · date: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. F2 · price: Reflects the weighted price of $16.60 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 22:33 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 278 | $17.25 | $4,795.50 |
DisclosureSEC source: 0000784199-17-000035 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,615 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 22:33 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 2,224 | $17.25 | $38,364.00 |
DisclosureSEC source: 0000784199-17-000035 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,893 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 22:31 UTC |
Gale David CVP, Research & Development
|
Tax withholdingCommon Stock | 417 | $17.25 | $7,193.25 |
DisclosureSEC source: 0000784199-17-000033 · certent-form4.xml · nonDerivative · entry 2 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,135 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 22:31 UTC |
Gale David CVP, Research & Development
|
Tax withholdingCommon Stock | 3,335 | $17.25 | $57,528.75 |
DisclosureSEC source: 0000784199-17-000033 · certent-form4.xml · nonDerivative · entry 1 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,552 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 22:28 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 417 | $17.25 | $7,193.25 |
DisclosureSEC source: 0000784199-17-000031 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,642 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 22:28 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 3,335 | $17.25 | $57,528.75 |
DisclosureSEC source: 0000784199-17-000031 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,059 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 22:27 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 695 | $17.25 | $11,988.75 |
DisclosureSEC source: 0000784199-17-000029 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,149 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 22:27 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 5,559 | $17.25 | $95,892.75 |
DisclosureSEC source: 0000784199-17-000029 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,884 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 14:10 UTC |
Capps Scott BVP, Clinical Research
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 16,667 | $16.40 Strike: $7.01 | $273,360.47 |
DisclosureSEC source: 0000784199-17-000027 · certent-form4.xml · derivative · entry 3 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,667 shares Expires 2017-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 14:10 UTC |
Capps Scott BVP, Clinical Research
|
SaleCommon Stock | 11,083 | $16.40 | $181,775.61 |
DisclosureSEC source: 0000784199-17-000027 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,394 F2 · price: Reflects weighted average price. Range was $16.35 to $16.45 The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 14:10 UTC |
Capps Scott BVP, Clinical Research
|
Exercise / conversionCommon Stock | 16,667 | $7.01 | $116,835.67 |
DisclosureSEC source: 0000784199-17-000027 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/22/2011 Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 00:03 UTC |
McDermid James MSVP, CHRO
|
GrantCommon Stock | 6,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000025 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,676 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 00:00 UTC |
Matthews William RobertSenior VP, Operations, Quality
|
GrantCommon Stock | 6,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000023 · certent-form4.xml · nonDerivative · entry 3 Matthews William Robert · CIK 0001649291 · Senior VP, Operations, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,300 F3 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:58 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 31,111 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000021 · certent-form4.xml · nonDerivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,449 F3 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:55 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 9,111 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000019 · certent-form4.xml · nonDerivative · entry 4 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,403 F3 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:53 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 5,111 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000017 · certent-form4.xml · nonDerivative · entry 4 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,117 F3 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:50 UTC |
Holloway Jean FVP, General Counsel
|
GrantCommon Stock | 7,536 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000015 · certent-form4.xml · nonDerivative · entry 4 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,153 F3 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:39 UTC |
Gale David CVP, Research & Development
|
GrantCommon Stock | 3,778 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000013 · certent-form4.xml · nonDerivative · entry 4 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,887 F3 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:36 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 7,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000011 · certent-form4.xml · nonDerivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,586 F3 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:33 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 4,444 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000009 · certent-form4.xml · nonDerivative · entry 4 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,810 F3 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| February 19, 2017 Filed Feb 23, 2017 00:00 UTC |
Matthews William RobertSenior VP, Operations, Quality
|
Tax withholdingCommon Stock | 2,212 | $17.25 | $38,157.00 |
DisclosureSEC source: 0000784199-17-000023 · certent-form4.xml · nonDerivative · entry 2 Matthews William Robert · CIK 0001649291 · Senior VP, Operations, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,020 F2 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 23, 2017 00:00 UTC |
Matthews William RobertSenior VP, Operations, Quality
|
GrantCommon Stock | 13,262 | $17.25 | $228,769.50 |
DisclosureSEC source: 0000784199-17-000023 · certent-form4.xml · nonDerivative · entry 1 Matthews William Robert · CIK 0001649291 · Senior VP, Operations, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,232 F1 · shares: Represents performance stock units granted on February 19, 2016 and earned at approximately 142.2% of target based on 2016 adjusted EBITDA. Fifty percent (50%) were issued on February 19, 2017. The remaining shares earned in connection with the February 2016 grant will vest and be issued as follows: 50% on 02/19/2018, and 50% on 02/19/2019, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:58 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 60,496 | $17.25 | $1,043,556.00 |
DisclosureSEC source: 0000784199-17-000021 · certent-form4.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,705 F2 · shares: Represents performance stock units granted on February 19, 2016 and earned at approximately 142.2% of target based on 2016 adjusted EBITDA. Fifty percent (50%) were issued on February 19, 2017. The remaining shares earned in connection with the February 2016 grant will vest and be issued as follows: 50% on 02/19/2018, and 50% on 02/19/2019, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:58 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 3,324 | $17.25 | $57,339.00 |
DisclosureSEC source: 0000784199-17-000021 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,209 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:58 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 13,367 | $17.25 | $230,580.75 |
DisclosureSEC source: 0000784199-17-000021 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,338 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:55 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 18,614 | $17.25 | $321,091.50 |
DisclosureSEC source: 0000784199-17-000019 · certent-form4.xml · nonDerivative · entry 3 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,396 F2 · shares: Represents performance stock units granted on February 19, 2016 and earned at approximately 142.2% of target based on 2016 adjusted EBITDA. Fifty percent (50%) were issued on February 19, 2017. The remaining shares earned in connection with the February 2016 grant will vest and be issued as follows: 50% on 02/19/2018, and 50% on 02/19/2019, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:55 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 1,330 | $17.25 | $22,942.50 |
DisclosureSEC source: 0000784199-17-000019 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,782 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:55 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 3,104 | $17.25 | $53,544.00 |
DisclosureSEC source: 0000784199-17-000019 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,292 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:53 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 10,471 | $17.25 | $180,624.75 |
DisclosureSEC source: 0000784199-17-000017 · certent-form4.xml · nonDerivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,751 F2 · shares: Represents performance stock units granted on February 19, 2016 and earned at approximately 142.2% of target based on 2016 adjusted EBITDA. Fifty percent (50%) were issued on February 19, 2017. The remaining shares earned in connection with the February 2016 grant will vest and be issued as follows: 50% on 02/19/2018, and 50% on 02/19/2019, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:53 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 518 | $17.25 | $8,935.50 |
DisclosureSEC source: 0000784199-17-000017 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,280 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.